CompletedNot Applicable

REmote Assessment and Dynamic Response Intervention

United States30 participantsStarted 2021-04-27

Plain-language summary

The purpose of the READyR study (originally called SHARE-sense) is to redevelop and test an intervention program to remotely assess for changing dementia-related care needs.

Who can participate

Age range62 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 62 years or older;
✓. Able to identify a family care partner over age 20 who is living with you and will also consent to fully participate in the study;
✓. Probable or confirmed diagnosis of mild cognitive impairment or early-stage dementia
✓. Age and education adjusted MOCA score \> 15 (at most recent measurement by parent study) corresponding to early to moderate stage dementia

Exclusion criteria

✕. Inability to speak English or read printed materials in English
✕. Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials);
✕. Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers.
✕. 21 years or older;
✕. Self-identifying as a family member and care partner residing with the PwD participant;
✕. Inability to speak English or read printed materials in English
✕. Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials);
✕. Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers.

What they're measuring

Mean difference effect sizes for pre-post change the care dyad's preparation for future care needs

Timeframe: Baseline, 6 weeks, 12 weeks

Mean difference effect sizes for pre-post change in the care dyad's relationship quality

Timeframe: Baseline, 6 weeks, 12 weeks

Trial details

NCT IDNCT04542109

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-17

View on ClinicalTrials.gov More Dementia trials